Amit Agarwal Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 1.00 M
as on 20-12-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Amit Agarwal Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agarwal and Dimple Agarwal serve as directors at the Company.
- CIN/LLPIN
U24290TG2022PTC158803
- Company No.
158803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Amit Agarwal Life Sciences Private Limited offer?
Amit Agarwal Life Sciences Private Limited offers a wide range of products and services, including Non Alcohol Drinks, Apple Juices, Herbal Extracts, Apple Extract, Flavors Aromatics, Apple Flavor.
Who are the key members and board of directors at Amit Agarwal Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agarwal  | Director | 14-Jan-2022 | Current |
| Dimple Agarwal | Director | 14-Jan-2022 | Current |
Financial Performance of Amit Agarwal Life Sciences.
Enhance accessibility to Amit Agarwal Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amit Agarwal Life Sciences?
Unlock access to Amit Agarwal Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Exosomes International Private LimitedActive 11 months 27 daysAmit Agarwal and Dimple Agarwal are mutual person
- Shrewsbury Lifestyle Private LimitedActive 2 years 6 months
Amit Agarwal and Dimple Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amit Agarwal Life Sciences?
Amit Agarwal Life Sciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amit Agarwal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amit Agarwal Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
